Tumour cells often exploit the tight regulation of MHC molecules at transcriptional, post‐transcriptional and post‐translational levels to downregulate MHC‐I expression, thereby escaping CD8+ T cell‐mediated immune surveillance. This evidence concerns the gene CD8A and neoplasm.